TY  - GEN
AU  - Schilling,Bastian
AU  - Martens,Alexander
AU  - Geukes Foppen,Marnix H
AU  - Gebhardt,Christoffer
AU  - Hassel,Jessica C
AU  - Rozeman,Elisa A
AU  - Gesierich,Anja
AU  - Gutzmer,Ralf
AU  - Kähler,Katharina C
AU  - Livingstone,Elisabeth
AU  - Diamantopoulos,Panagiotis T
AU  - Gogas,Helen
AU  - Madonna,Gabriele
AU  - Ascierto,Paolo A
AU  - Goldinger,Simone M
AU  - Mangana,Johanna
AU  - Garbe,Claus
AU  - Schadendorf,Dirk
AU  - Blank,Christian
AU  - Weide,Benjamin
TI  - First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis
SN  - 1432-0851
PY  - 2019///0522
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cohort Studies
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - antagonists & inhibitors
KW  - Humans
KW  - Melanoma
KW  - drug therapy
KW  - Neoplasm Metastasis
KW  - Nivolumab
KW  - Programmed Cell Death 1 Receptor
KW  - immunology
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Mas
KW  - Proto-Oncogene Proteins B-raf
KW  - Retrospective Studies
KW  - Signal Transduction
KW  - Skin Neoplasms
KW  - Survival Analysis
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00262-019-02311-1
ER  -